Kropotova Alexandra
Transaction: 03/24/2026
SELL
Change
-988
Price
Not reported
Filing
03/25/2026
Type
SELL
SAB Biotherapeutics, Inc.
SABS • Biotechnology
$3.72
— 0.00 (0.00%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$36.99M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Reasonable earnings multiple · 5.44Manageable debt level · 0.04Healthy liquidity · 9.46Negative growth trendWeak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 12, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$3.72
Change0.00%
Market Cap$36.99M
52W Range1.67 - 6.60
Beta0.55
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.04
Current Ratio9.46
Quick Ratio9.46
Revenue 5Y-100.00%
Price$3.72
Change0.00%
Market Cap$36.99M
52W Range1.67 - 6.60
Beta0.55
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.04
Current Ratio9.46
Quick Ratio9.46
Revenue 5Y-100.00%
Target$10.25
Target Upside175.54%
Target Median$10.50
Target Range7.00 - 13.00
Volume353.55K
Avg Volume794.72K
EPS Surprise-0.15
Investment DNA
How strong this company looks for long-term investors
43
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Reasonable earnings multiple · 5.44Manageable debt level · 0.04Healthy liquidity · 9.46Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-06-26
Low
$7.00
Mean
$10.25
Median
$10.50
High
$13.00
Insider Transactions
Recent executive and insider activity
To Lucy
Transaction: 02/03/2026
BUY
Change
+2,400,000
Price
$4.45
Filing
02/05/2026
Type
BUY
Kropotova Alexandra
Transaction: 02/03/2026
BUY
Change
+2,400,000
Price
$4.45
Filing
02/05/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Kropotova Alexandra | SELL | -988 | Not reported | 03/24/2026 | 03/25/2026 |
| To Lucy | BUY | +2,400,000 | $4.45 | 02/03/2026 | 02/05/2026 |
| Kropotova Alexandra | BUY | +2,400,000 | $4.45 | 02/03/2026 | 02/05/2026 |
| Bausch Christoph Lawrence | BUY | +1,800,000 | $4.45 | 02/03/2026 | 02/05/2026 |
| Reich Samuel J | BUY | +4,800,000 | $4.45 | 02/03/2026 | 02/05/2026 |
| Sullivan Eddie Joe | BUY | +3,000,000 | $4.45 | 02/03/2026 | 02/05/2026 |
| ZACCARDELLI DAVID | OTHER | 0 | Not reported | 01/05/2026 | 01/07/2026 |
| Jain Rita | OTHER | 0 | Not reported | 01/05/2026 | 01/07/2026 |
| ZACCARDELLI DAVID | BUY | +240,000 | $3.74 | 01/05/2026 | 01/07/2026 |
| Jain Rita | BUY | +240,000 | $3.74 | 01/05/2026 | 01/07/2026 |
| Link David | BUY | +150,000 | $3.99 | 12/16/2025 | 12/18/2025 |
| Giberson Scott | BUY | +150,000 | $3.99 | 12/16/2025 | 12/18/2025 |
| Ellias Helen K. | BUY | +150,000 | $3.99 | 12/16/2025 | 12/18/2025 |
| Lucera Erick | BUY | +150,000 | $3.99 | 12/16/2025 | 12/18/2025 |
| Polvino William James | BUY | +150,000 | $3.99 | 12/16/2025 | 12/18/2025 |
| SKYLER JAY S | BUY | +150,000 | $3.99 | 12/16/2025 | 12/18/2025 |
| Kropotova Alexandra | SELL | -988 | Not reported | 12/11/2025 | 12/12/2025 |
| Sessa Capital (Master), L.P. | SELL | -17,400 | $1.75 | 09/29/2025 | 10/01/2025 |
| Sessa Capital (Master), L.P. | BUY | +1,740,000 | $1.75 | 09/29/2025 | 10/01/2025 |
| Moin Andrew | SELL | -17,400 | $1.75 | 09/29/2025 | 10/01/2025 |